Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 92 results for "ranjit kapadia"

Sell Ranbaxy; target Rs 270: Ranjit Kapadia
Money Control

Sell Ranbaxy; target Rs 270: Ranjit Kapadia

Ranjit Kapadia, pharma analyst of Centrum Broking suggests selling Ranbaxy Laboratories with a target Rs 270. Money Control, 1 month ago

5 images for ranjit kapadia

Rediff.com, 1 day ago
Rediff.com, 2 weeks ago
Money Control, 1 month ago
Moneycontrol.com, 2 months ago
Moneycontrol.com, 4 months ago

Except Japan, Lupin saw good growth in all mkts: Centrum

Ranjit Kapadia, Senior VP - Pharma - Centrum Broking says the firms numbers are very good on the top-line and margins front.
 Money Control2 months ago
Hindu Business Line

Pharma giants Novartis, GSK swap assets in $23-b deal

Drug majors Novartis AG and GlaxoSmithKline Plc have agreed to buy key businesses from each other in a three-part transaction that will re-define the international marketplace. As part of the global deal, GlaxoSmithKline's (GSK) cancer drugs ...
 Hindu Business Line1 day ago
Livemint.com

Novartis to buy Glaxo's cancer drugs for $16 billion

The transactions culminate a process that began last year when Novartis chief executive offer Joe Jimenez began reviewing the company's smaller businesses for possible sale. London/Mumbai: Novartis AG agreed to buy GlaxoSmithKline Plc 's (GSK's) ...
 Livemint.com1 day ago
Business Standard India

Is Dilip Shanghvi's big bet worth the risk?

Ranbaxy's frequent run-ins with the US FDA may have proved too much for its previous owner, Japan's Daiichi Sankyo, but for Sun Pharma, it is an astute purchase that it hopes will not only boost its position in India but also globally Reghu ...
 Business Standard India2 days ago Why Ranbaxy Buy Is Not The Biggest Risk For Sun's Shanghvi  Businessworld India2 weeks ago No immediate cure for GSK Pharma's ailments  Business Standard India2 months ago
Rediff.com

Domestic Prices Of Bulk Drugs From India Likely To Increase This Year

By Marcus Johnson The growth of bulk drugs exported from India has slowed in recent months, due to regulatory questions from the U.S. and the EU. However, the price of bulk drugs is expected to increase in India this year. Because of inflation ...
 Pharmaceutical Online1 week ago Bulk drug prices may rise this fiscal  Rediff.com1 week ago Bulk drug prices likely to increase this fiscal  Business Standard India1 week ago

Signs of revival

the pharma sector has been showing some signs of revival, particularly in the domestic sector. And with the recent acquisition of Gurgaon-based Ranbaxy Laboratories by Sun Pharmaceutical Industries, the sector may see consolidation going forward. ...
 Financial Chronicle1 week ago
Times of India

Malayalam dialogues give me panic attacks: Seema Biswas

During her school days, Seema Biswas used to often travel in buses alone. Being a timid, quiet girl, she never initiated conversations with anyone. However, people sharing seats with her would often steal a glance or two at Seema and ask in Hindi, ...
 Times of India1 week ago

Sun Pharma to face challenges in rectifying quality control

Sun Pharma management may face considerable challenges in rectifying a long history of quality control and regulatory problems plaguing Ranbaxy's recent performance, according to analysts. But given Sun Pharma's managing director Dilip Shanghvi's ...
 Financial Chronicle2 weeks ago
Business Standard India

Sun Pharma-Ranbaxy deal: Sunshine for Ranbaxy

Related to : Ranbaxy Laboratories Ltd,Sun Pharmaceuticals Industries Ltd Ranbaxy Laboratories Ltd BSE 07 Apr 14 | 12:00 AM 445.20 -14.35 (-3.12%) NSE 07 Apr 14 | 12:00 AM 445.75 -13.8 (-3%) Sun Pharmaceutical Industries buyout of ...
 Smart Investor2 weeks ago Sunshine for Ranbaxy  Business Standard India2 weeks ago Sunshine for Ranbaxy as Sun rises higher  Business Standard India2 weeks ago 5 challenges for Sun in Ranbaxy deal | Shanghvi, pharma maven with midas touch  Economic Times2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranjit kapadia
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less